Evaluating TG Therapeutics: Insights From 4 Financial Analysts
Evaluating TG Therapeutics: Insights From 4 Financial Analysts
評估tg therapeutics：來自4位財務分析師的見解
A clear picture of TG Therapeutics's perception among financial...During the last three months, 4 analysts shared their evaluations of TG Therapeutics (NASDAQ:TGTX), revealing diverse outlooks from bullish to bearish.
在過去的三個月裏，有4位分析師對TG Therapeutics (納斯達克:TGTX)進行了評估，顯示出從看好到看淡的不同觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $38.0, a high estimate of $49.00, and a low estimate of $20.00. Observing a 4.83% increase, the current average has risen from the previous average price target of $36.25.
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $38.0, a high estimate of $49.00, and a low estimate of $20.00. Observing a 4.83% increase, the current average has risen from the previous average price target of $36.25.
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
A clear picture of TG Therapeutics's perception among financial...
通過對最近分析師行動...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間